Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Equity Average: 2010-2025

Historic Equity Average for UNITED THERAPEUTICS (UTHR) over the last 15 years, with Sep 2025 value amounting to $6.9 billion.

  • UNITED THERAPEUTICS's Equity Average rose 16.66% to $6.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 billion, marking a year-over-year increase of 16.66%. This contributed to the annual value of $6.2 billion for FY2024, which is 15.28% up from last year.
  • UNITED THERAPEUTICS's Equity Average amounted to $6.9 billion in Q3 2025, which was down 1.55% from $7.0 billion recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Equity Average ranged from a high of $7.0 billion in Q2 2025 and a low of $3.4 billion during Q1 2021.
  • Over the past 3 years, UNITED THERAPEUTICS's median Equity Average value was $5.8 billion (recorded in 2023), while the average stood at $6.0 billion.
  • Data for UNITED THERAPEUTICS's Equity Average shows a peak YoY increased of 26.69% (in 2025) over the last 5 years.
  • UNITED THERAPEUTICS's Equity Average (Quarterly) stood at $3.9 billion in 2021, then increased by 20.16% to $4.7 billion in 2022, then increased by 24.98% to $5.8 billion in 2023, then grew by 7.25% to $6.3 billion in 2024, then grew by 16.66% to $6.9 billion in 2025.
  • Its Equity Average was $6.9 billion in Q3 2025, compared to $7.0 billion in Q2 2025 and $6.6 billion in Q1 2025.